Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Fixed Capital/Sales

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.350.340.310.270.24

What is the latest Fixed Capital/Sales ratio of AUROBINDO PHARMA ?

The latest Fixed Capital/Sales ratio of AUROBINDO PHARMA is 0.35 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.35
Mar20230.34
Mar20220.31
Mar20210.27
Mar20200.24

How is Fixed Capital/Sales of AUROBINDO PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.35
2.94
Mar2023 0.34
9.68
Mar2022 0.31
14.81
Mar2021 0.27
12.50
Mar2020 0.24 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Fixed Capital/Sales ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹66,829.8 Cr -0.9% -5.5% -7.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,176.0 Cr -0.3% -2.9% 11.5% Stock Analytics
DIVIS LABORATORIES ₹177,076.0 Cr 0.7% 7.4% 48.1% Stock Analytics
CIPLA ₹121,592.0 Cr -0.1% 0.2% -2.1% Stock Analytics
DR REDDYS LABORATORIES ₹113,615.0 Cr 3.2% 10.3% 11.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,024.0 Cr 2.3% -0.5% 13.8% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.9%

-5.5%

-7.5%

SENSEX

-1.3%

-0.3%

5.8%


You may also like the below Video Courses